Epic has formed a partnership with molecular science company Caris Life Sciences for integration of its portfolio of services into Epic's network.
The partnership means that Epic will have access to Caris' suite of molecular profile services, including whole genetic testing for blood and tissue samples, according to the July 7 press release. Epic will add the capabilities to its "orders and results anywhere" network to be made available later this year. The partnership will integrate test ordering and results into Epic, helping to streamline clinical workflows.
"Integrations like ours with Caris Life Sciences directly benefit patients by improving access and efficiency to testing results that lead to informed treatment decisions," said Alan Hutchison, vice president of population health at Epic. "We are excited for this enhanced partnership with Caris to further increase health access and care, and the opportunity to help deliver precision medicine to a greater number of communities."